Season 3
Season 2
Season 1
Against All Odds: Finding a Treatment for SPG50
In a deeply personal and moving episode, two patient advocates share their stories of working tirelessly to deliver safe and effective gene therapy for children suffering from spastic paraplegia 50 (SPG50).
Are We Too Risk Averse in Clinical Research?
TGuest: Ken Getz, Executive Director and Research Professor, Tufts Center for the Study of Drug DevelopmentThis week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP’s work to improve public trust in scientific advances.
Putting Patient Data at the Heart of Your Strategy
Terttu Haring, president of sites and patients, Syneos HealthLeonie Christianson, director, R&D advisory, Syneos Health
In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect insights from large volumes of data. But has this influx of data and tech caused us to move farther away from the patients we serve? This episode outlines the major opportunities for life sciences organizations to put patients back at the heart of clinical strategy.
Sites Are Voicing Their Concerns, But Are We Listening?
Vivienne van de Walle, Medical Director & Founder, PT&RBree Burks, VP, Site Solutions Strategy, Veeva
In this week’s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&R (an independent research site in the Netherlands), and Bree Burks. In this episode, Vivienne and Bree explain the tangible ways that sites (and patients) are hurt by inconsistent technology and the steps to make it better.
Transforming Clinical Operations: What Comes Next?
Emma Earl, Head of Clinical Trial Management Services and Solutions, BayerIn this episode, Richard Young speaks with Bayer’s Head of Clinical Trial Management Services and Solutions, Emma Earl. Together they outline the major opportunities and the missing ingredients for delivering efficient and patient-centric clinical trials.
The State of Clinical Trials in the U.K. and Europe
Chris Moore, President, Veeva EuropeWe have a special episode for you this week! In a twist to our usual format, Nicole Raleigh of Pharmaphorum is in the host seat interviewing Veeva’s Chris Moore about his outlook on clinical trials in the U.K. and Europe.
Clinical Data Innovation In A Non-EDC Centric World
Patrick Nadolny, global head of clinical data management, SanofiThis week, Richard Young speaks to Patrick Nadolny, global head of clinical data management, Sanofi.
Takeaways from Veeva's R&D and Quality North America Summit
Guest: Jim Reilly, VP, Development Cloud Strategy, VeevaThey discuss learnings from Veeva’s recent North American R&D and Quality Summit — including observations and trends from hundreds of biopharmas.
Debunking the Myths of AI
Guests: Andy Cooper, CEO of CluepointsDoes ChatGPT understand data from clinical trials? Andy Cooper, CEO of Cluepoints, explains why industry context will be critical for the success of AI and machine learning initiatives in clinical data.
Does Patient Choice Equal Site Headaches?
Guests: Helen Shaw, Co-Founder and Managing Director, VCTCMarie-Claire Flavin, Director, Customer Success, Veeva Site Solutions (EMEA)
This episode covers novel ways that sites are using technology to expand patient choice in clinical research without compromising operational efficiency.
Why We Need to Expand Patient Choice in Clinical Trials
Guest: Tim Davis, Vice President of Strategy for MyVeeva for PatientsThis week, Richard Young speaks to Tim Davis, Vice President of Strategy for MyVeeva for Patients. In recent years, decentralized clinical trials, patient centricity, and site centricity have become buzzwords for sponsors and CROs. But positive change starts with expanding patient choice during clinical trials.
How Can We Prepare for the Future of Clinical Trials?
Guest: Rhona O’Donnell, VP, Data Management Systems and Standards at Novo NordiskThis week, Richard Young is joined by Rhona O’Donnell, VP, Data Management Systems and Standards at Novo Nordisk. They discuss the evolution of the data management role, and how we can prepare for the future through collaboration and more effective training for the next generation.
Are We Any Closer to Patient-Centric Trials?
Guest: Alan Morgan, CEO Advisor of ExcelyaThis week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years, sponsors and CROs have invested heavily in “big data” tools for site selection and productivity. But has that investment paid off?
Is Data Management the Glue of Modern Clinical Trials?
Guest: Luis E. Torres, Head of Clinical Programming FSPx, LabcorpListen to how data managers can prepare for the future of clinical trials by adopting new technologies and skills that will keep decentralized clinical teams connected.
Data Managers: Driving the Future of Clinical Research
Guest: Mayank Anand, VP and Global Head of Data Strategy and Management, GSKIn this week’s conversation, hear how clinical data professionals’ roles are evolving in a world of decentralized data. It’s a great time to be a clinical data professional, they agree, as a once invisible role moves front and center to optimize trial protocols, operations, and results and speed patient access to better treatments.
How Will RTSM Impact Clinical Data?
Guest: Natalie Townsend, VP Strategy, Veeva RTSMRichard Young speaks to Natalie Townsend, the global lead for Randomization and Trial Supply Management (RTSM) strategy at Veeva. They discuss the evolution of ‘digital’ clinical trials from the early days of phone-based and spreadsheet-centered activities to the role technology is playing today.
How Clean is Your Data?
Guest: Trevor Griffiths, Senior Director for Clinical Data Management, Syneos HealthRichard Young speaks to Trevor Griffiths, senior director for clinical data management at Syneos Health. Data management is becoming much more complex for CROs, as trials become larger and data sources more diverse.
Will Traditional EDC Exist 10 Years From Now?
Guest: Doug Bain, Chief Technology Office, KCRRichard Young speaks to Doug Bain, chief technology officer at KCR, a contract research organization (CRO). They discuss the role of electronic data capture (EDC) in today’s complex, dynamic clinical trial landscape.
What Should Be in Your Digital Trial Toolkit?
Guest: Tanya du Plessis, Chief Data Strategist and Solutions Officer, BioforumRichard Young speaks to Tanya du Plessis, chief data strategist and solutions officer at Bioforum the Data Masters, a data-focused CRO. The old days of linear trial processes and pushing paper are thankfully over, presenting exciting opportunities in clinical data management.
Life Sciences in Europe: Breaking Down the Barriers
Guest: Chris Moore, President, Veeva EuropeAfter more than two years apart, European life sciences came together in Zurich in June. There are big advances underway that will make clinical research faster, better connected, and more patient-centric. But there’s also frustration at the silo-driven approach.
State of Digital Clinical Trials is a Veeva podcast hosted by Richard Young, Vice President, Strategy, Clinical Data at Veeva. Over the next few months, Richard will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.